The role of gut-brain axis in a rotenone-induced rat model of Parkinson's disease

[1]  K. Murros,et al.  Desulfovibrio bacteria enhance alpha-synuclein aggregation in a Caenorhabditis elegans model of Parkinson’s disease , 2023, Frontiers in Cellular and Infection Microbiology.

[2]  A. Thaler,et al.  Diagnosis and Medical Management of Parkinson Disease , 2022, Continuum.

[3]  V. Ramesh,et al.  Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networks , 2022, npj Digital Medicine.

[4]  Richard J Smeyne,et al.  Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice , 2022, Neurobiology of Disease.

[5]  S. Broadley,et al.  Effects of Cannabis in Parkinson’s Disease: A Systematic Review and Meta-Analysis , 2021, Journal of Parkinson's Disease.

[6]  S. Duty,et al.  Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research , 2021, Neuronal signaling.

[7]  R. Silva,et al.  Female Rats Are Resistant to Cognitive, Motor and Dopaminergic Deficits in the Reserpine-Induced Progressive Model of Parkinson’s Disease , 2021, Frontiers in Aging Neuroscience.

[8]  Josephine Trichka,et al.  Modulation of Neuroinflammation by the Gut Microbiota in Prion and Prion-Like Diseases , 2021, Pathogens.

[9]  Yong Tang,et al.  Gut Microbiota Regulate Astrocytic Functions in the Brain: Possible Therapeutic Consequences , 2021, Current neuropharmacology.

[10]  E. Souza,et al.  The Alpha-Lipoic Acid Improves Survival and Prevents Irinotecan-Induced Inflammation and Intestinal Dysmotility in Mice , 2020, Pharmaceuticals.

[11]  C. Piperi,et al.  Emerging role of S100B protein implication in Parkinson’s disease pathogenesis , 2020, Cellular and Molecular Life Sciences.

[12]  R. Balling,et al.  Neurodegeneration and neuroinflammation are linked, but independent of α-synuclein inclusions, in a seeding/spreading mouse model of Parkinson’s disease , 2020, bioRxiv.

[13]  M. D. Turner,et al.  Role of S100 proteins in health and disease. , 2020, Biochimica et biophysica acta. Molecular cell research.

[14]  T. Brudek.  Inflammatory Bowel Diseases and Parkinson’s Disease , 2019, Journal of Parkinson's disease.

[15]  Jin-song Liu,et al.  Colonic electrical stimulation improves colonic transit in rotenone-induced Parkinson's disease model through affecting enteric neurons. , 2019, Life sciences.

[16]  Benedict Michael,et al.  Faculty Opinions recommendation of Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[17]  Ruixue Huang,et al.  Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson's disease model , 2019, Redox biology.

[18]  M. Kreft,et al.  Metabolic Plasticity of Astrocytes and Aging of the Brain , 2019, International journal of molecular sciences.

[19]  P. Guest,et al.  The Open Field Test for Measuring Locomotor Activity and Anxiety-Like Behavior. , 2018, Methods in molecular biology.

[20]  G. Halliday,et al.  Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice , 2018, Neurobiology of Disease.

[21]  C. Glass,et al.  Microbiome–microglia connections via the gut–brain axis , 2018, The Journal of experimental medicine.

[22]  Yoshihiro Kokubo,et al.  Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet Neurology.

[23]  Yifei Wang,et al.  The Gut-Microglia Connection: Implications for Central Nervous System Diseases , 2018, Front. Immunol..

[24]  M. Tremblay,et al.  Microglial Implication in Parkinson’s Disease: Loss of Beneficial Physiological Roles or Gain of Inflammatory Functions? , 2018, Front. Cell. Neurosci..

[25]  B. Pakkenberg,et al.  Authors’ response: Association between IBD and Parkinson’s disease: seek and you shall find? , 2018, Gut.

[26]  J. Ludvigsson,et al.  Association between inflammatory bowel disease and Parkinson’s disease: seek and you shall find? , 2018, Gut.

[27]  A. Stringer,et al.  Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson’s disease , 2018, Neurotoxicology.

[28]  Wei Zhang,et al.  Parkinson disease with constipation: clinical features and relevant factors , 2018, Scientific Reports.

[29]  R. Wade-Martins,et al.  Are rodent models of Parkinson’s disease behaving as they should? , 2017, Behavioural Brain Research.

[30]  X. Teng,et al.  MicroRNA-7-5p regulates the proliferation and migration of intestinal epithelial cells by targeting trefoil factor 3 via inhibiting the phosphoinositide 3-kinase/Akt signalling pathway , 2017, International journal of molecular medicine.

[31]  H. Matsuno,et al.  Body weight and dysautonomia in early Parkinson's disease , 2017, Acta neurologica Scandinavica.

[32]  M. Bolliger,et al.  LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies , 2017, Movement disorders : official journal of the Movement Disorder Society.

[33]  Manoj Kumar,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[34]  Jung-Chun Lin,et al.  Association Between Parkinson's Disease and Inflammatory Bowel Disease: a Nationwide Taiwanese Retrospective Cohort Study , 2016, Inflammatory bowel diseases.

[35]  Syed F. Ali,et al.  Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models. , 2015, Brain : a journal of neurology.

[36]  T. Maniatis,et al.  Astrocytes in neurodegenerative disease. , 2015, Cold Spring Harbor perspectives in biology.

[37]  Georg Auburger,et al.  The Brainstem Pathologies of Parkinson's Disease and Dementia with Lewy Bodies , 2015, Brain pathology.

[38]  E. Tolosa,et al.  The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PD Study) , 2015, Movement disorders : official journal of the Movement Disorder Society.

[39]  R. Wu,et al.  Risk of Parkinson's disease following severe constipation: a nationwide population-based cohort study. , 2014, Parkinsonism & related disorders.

[40]  M. Vassallo,et al.  Prognostic significance of weight changes in Parkinson's disease: the Park-weight phenotype. , 2014, Neurodegenerative disease management.

[41]  P. Lucassen,et al.  Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson’s disease patients , 2014, Acta Neuropathologica Communications.

[42]  P. Krack,et al.  Mechanisms of Body Weight Fluctuations in Parkinson’s Disease , 2014, Front. Neurol..

[43]  F. Pitossi,et al.  Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson’s Disease? , 2013, Front. Cell. Neurosci..

[44]  P. Aubert,et al.  Effects of oral administration of rotenone on gastrointestinal functions in mice , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[45]  J. Sharma,et al.  Olfaction, dyskinesia and profile of weight change in Parkinson's disease: identifying neurodegenerative phenotypes. , 2012, Parkinsonism & related disorders.

[46]  R. Ribeiro,et al.  Role of inducible nitric oxide synthase pathway on methotrexate-induced intestinal mucositis in rodents , 2011, BMC gastroenterology.

[47]  H. Adami,et al.  Epidemiology and etiology of Parkinson’s disease: a review of the evidence , 2011, European Journal of Epidemiology.

[48]  A. Prescott,et al.  14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization , 2010, The Biochemical journal.

[49]  S. Kitazawa,et al.  A rotarod test for evaluation of motor skill learning , 2010, Journal of Neuroscience Methods.

[50]  C. Heizmann,et al.  Binding of S100 proteins to RAGE: an update. , 2009, Biochimica et biophysica acta.

[51]  Victor Tapias,et al.  A highly reproducible rotenone model of Parkinson's disease , 2009, Neurobiology of Disease.

[52]  Xiaomin Su,et al.  Mutant α-Synuclein Overexpression Mediates Early Proinflammatory Activity , 2009, Neurotoxicity Research.

[53]  A. Zapf,et al.  Dopaminergic treatment is associated with decreased body weight in patients with Parkinson’s disease and dyskinesias , 2009, European journal of neurology.

[54]  He-Jin Lee,et al.  Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. , 2008, Biochemical and biophysical research communications.

[55]  R. Paffenbarger,et al.  Body mass index and risk of Parkinson's disease: a prospective cohort study. , 2007, American journal of epidemiology.

[56]  S. Laurberg,et al.  Clinical aspects of bowel symptoms in Parkinson’s disease , 2007, Acta neurologica Scandinavica.

[57]  A M Stiggelbout,et al.  Patient-reported autonomic symptoms in Parkinson disease , 2007, Neurology.

[58]  M. Cookson,et al.  Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin–proteasome system , 2006, Neurobiology of Disease.

[59]  T. Südhof,et al.  Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[60]  C. Tanner,et al.  Parkinsonian signs and substantia nigra neuron density in decendents elders without PD , 2004, Annals of neurology.

[61]  M. Unosson,et al.  Factors of importance for weight loss in elderly patients with Parkinson's disease , 2004, Acta neurologica Scandinavica.

[62]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[63]  Miguel A Hernán,et al.  Weight loss in Parkinson's disease , 2003, Annals of neurology.

[64]  R. Sakakibara,et al.  Colonic transit time and rectoanal videomanometry in Parkinson’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[65]  G. Bing,et al.  Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration , 2003, Neurobiology of Disease.

[66]  W. Schmidt,et al.  Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats , 2002, Behavioural Brain Research.

[67]  J. Dekker,et al.  Distinct epithelial responses in experimental colitis: implications for ion uptake and mucosal protection. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[68]  C. Heizmann,et al.  S100 proteins: structure, functions and pathology. , 2002, Frontiers in bioscience : a journal and virtual library.

[69]  W. Stremmel,et al.  Interleukin-6 expression and regulation in rat enteric glial cells. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[70]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[71]  D. Gash,et al.  Effect of bilateral 6-OHDA lesions of the substantia nigra on locomotor activity in the rat , 1994, Brain Research.

[72]  R N Walsh,et al.  The Open-Field Test: a critical review. , 1976, Psychological bulletin.

[73]  A. Murphy,et al.  S100 family proteins in inflammation and beyond. , 2020, Advances in clinical chemistry.

[74]  M. Ho.  Microglia in Parkinson's Disease. , 2019, Advances in experimental medicine and biology.

[75]  T. Dawson,et al.  Nitric Oxide Signaling in Neurodegeneration and Cell Death. , 2018, Advances in pharmacology.

[76]  J. Volkmann,et al.  Parkinson disease , 2017, Nature Reviews Disease Primers.

[77]  R. Pfeiffer.  Non-motor symptoms in Parkinson's disease. , 2016, Parkinsonism & related disorders.

[78]  K. Walters,et al.  Prediagnostic presentations of Parkinson's disease in primary care: a case-control study , 2015, The Lancet Neurology.

[79]  M. Block,et al.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.

[80]  笠井 憲雪.  International Guiding Principles for Biomedical Research Involving Animals , 1985, Alternatives to laboratory animals : ATLA.